Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Disease area: Interstitial lung diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Pascual-González (L'Hospitalet de Llobregat, Spain), E. Cuevas (L'Hospitalet de Llobregat, Spain), P. Luburich (L'Hospitalet de Llobregat, Spain), V. Vicens-Zygmunt (L'Hospitalet de Llobregat, Spain). Pulmonary alveolar microlithiasis: genetic disorder and concomitant altered calcium metabolism. 3490

Member's Comments

No comment yet.

Related content which might interest you: Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult Source: Eur Respir J, 55 (4) 1901952; 10.1183/13993003.01952-2019 Year: 2020 Association of pulmonary alveolar proteinosis and fibrosis: patient with GATA2 deficiency Source: Eur Respir J 2016; 48: 1510-1514 Year: 2016 New mutation associated to the pulmonary alveolar microlithiasis Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Pulmonary alveolar microlithiasis: two case reports and review of the literature Source: Eur Respir Rev 2012 21:249-256 Year: 2012 Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 152-160 Year: 2012 Regulation disorders of pulmonary lipid metabolism in chronic obstructive pulmonary disease Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019 Thyroid hormone inhibits pulmonary fibrosis through enhancement of mitochondrial function in alveolar epithelial cells Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Contribution of epithelial-to-mesenchymal transition to phenotypic changes in idiopathic interstitial pneumonias Source: International Congress 2015 – New insights into IIPs Year: 2015 The role of extracellular vesicles in phenotypic alteration of lung cells in pulmonary fibrosis Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Differential metabolism of hyaluronic acid in patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Peculiarities of pulmonary alveolar proteinosis (PAP) due to exogenous factors Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease Year: 2020 Pulmonary emphysema and idiopathic pulmonary fibrosis: Is the pattern of exercise-induced oxygen desaturation same or different? Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Lung fibrosis in Pulmonary Alveolar Proteinosis (PAP): different stages of a syndrome or distinct diseases? Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Abnormal intraalveolar accumulation of surfactant proteins in adults with pulmonary alveolar proteinosis Source: Eur Respir J 2002; 20: Suppl. 38, 90s Year: 2002 Dysregulation of iron homeostasis in Eisenmenger syndrome; comparison to idiopathic pulmonary arterial hypertension and healthy controls Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Pulmonary alveolar microlithiasis Source: International Congress 2019 – Insights into paediatric bronchology Year: 2019 Pulmonary alveolar microlithiasis Source: Eur Respir Rev, 29 (158) 200024; 10.1183/16000617.0024-2020 Year: 2020 Iron deficiency is common in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2011; 37: 1386-1391 Year: 2011 Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Nutritional intervention in cystic fibrosis Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=153 Year: 2003